Board Member
Treace Medical Concepts, Inc. (TMCI)Equibles does not estimate personal net worth.
Get an email with a short summary when Treace Medical Concepts, Inc. publishes a filing, an earnings call transcript or a press release.
Get TMCI alertsJohn Treace is recorded as CEO and Board Member at Treace Medical Concepts, Inc. (TMCI). The newest filing on record that lists John Treace as CEO at Treace Medical Concepts, Inc. (TMCI) is dated April 6, 2026. The newest filing on record that lists John Treace as Board Member at Treace Medical Concepts, Inc. (TMCI) is dated April 7, 2025. The proxy statement of Treace Medical Concepts, Inc. reports total compensation of $5,405,190 for John Treace in fiscal 2025, including a base salary of $755,353. Disclosed compensation is on record for 6 fiscal years. John Treace has spoken on 21 earnings calls across 1 company, most recently for Treace Medical Concepts, Inc. on August 7, 2026. Treace Medical Concepts, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Treace Medical Concepts, Inc. includes Mark L. Hair (CFO) and Betsy Hanna (Board Member).
“Good morning, everyone, and thank you for joining us on our second quarter 2026 earnings conference call. We are pleased with our results in the second quarter, with our revenue growth rate improving sequentially and our focus on profitability generating stronger adjusted EBITDA and reduced cash usage over prior year.”
“Good morning, everyone, and thank you for joining us on our first quarter 2026 earnings conference call. Entering 2026, Treece Medical has evolved beyond its foundation in lapoplasty into a comprehensive Bunyan Solutions company.”
“Good morning, everyone, and thank you for joining us on our fourth quarter 2025 earnings conference call. During 2025, Treese Medical entered a transformational phase, building upon our leadership as recognized Bunyan experts and evolving from a lapoplasty focused company into a comprehensive bunion solutions company.”
“Good afternoon, everyone, and thank you for joining us on our third quarter 2025 earnings conference call.”
“Good afternoon, everyone, and thank you for joining us for our second quarter 2025 earnings conference call.”
Start not stated–present
Last confirmed April 6, 2026
Start not stated–present
Last confirmed April 7, 2025
Medical Devices · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Treace Medical Concepts, Inc. (TMCI) | Chief Executive Officer, Founder and Board Chair | $755,353 | $5,405,190 |
| 2024 | Treace Medical Concepts, Inc. (TMCI) | Chief Executive Officer, Director and Founder | $723,410 | $6,597,160 |
| 2023 | Treace Medical Concepts, Inc. (TMCI) | Chief Executive Officer, Director and Founder | $684,384 | $8,422,635 |
| 2022 | Treace Medical Concepts, Inc. (TMCI) | Chief Executive Officer, Director and Founder | $568,219 | $3,617,249 |
| 2021 | Treace Medical Concepts, Inc. (TMCI) | Chief Executive Officer, Director and Founder | $410,141 | $688,145 |
| 2020 | Treace Medical Concepts, Inc. (TMCI) | Chief Executive Officer, Director and Founder | $316,153 | $392,399 |
